Benzinga
11 Nov 2025, 16:40 UTC · 44w ago
Verdict
Headline leans bearish. We score OGN −0.40 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−0.40moderately bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish
Organon lowered its fiscal sales guidance to a range of $6.20 billion to $6.25 billion, falling below the previous range and analyst consensus.
More negative than 92% of claims this week
Organon reported Q3 adjusted earnings of $1.01 per share and sales of $1.602 billion, both beating Wall Street estimates.
So whatBeating quarterly expectations shows strong current operational performance, providing a partial buffer against the guidance cut.
Continue reading
5 related stories
More negative than 77% of ticker scores this week
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 64% of claims this week
The company expects to generate more than $900 million in free cash flow before one-time costs this year.
More positive than 53% of claims this week
Which stocks this story touches
More negative than 77% of ticker scores this week
Despite beating Q3 earnings and sales estimates, the company lowered its fiscal sales guidance, leading to a 3.4% drop in share price.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
1d ago
—
No price for OGN right now — the quote feed didn't answer.
OGN chart →
